Masenga, Sepiso K. https://orcid.org/0000-0003-4376-5831
Pilic, Leta https://orcid.org/0000-0001-8046-1269
Hamooya, Benson M. https://orcid.org/0000-0003-1385-0998
Nzala, Selestine https://orcid.org/0000-0002-2065-3987
Heimburger, Douglas C. https://orcid.org/0000-0003-3551-9710
Mutale, Wilbroad https://orcid.org/0000-0002-4891-6750
Koethe, John R. https://orcid.org/0000-0001-6490-6942
Kirabo, Annet https://orcid.org/0000-0001-8580-9359
Munsaka, Sody M. https://orcid.org/0000-0002-6917-3888
Elijovich, Fernando https://orcid.org/0000-0002-2511-056X
Funding for this research was provided by:
fogarty international center (D43 TW009744, D43 TW009337)
National Institutes of Health (K01HL130497, R03HL155041, and R01HL144941)
Article History
Received: 4 August 2021
Accepted: 6 May 2022
First Online: 15 September 2022
Declarations
:
: This study was approved by the University of Zambia Biomedical Research Ethics committee (IRB00001131 of IORG0000774) and the National Health Research Ethics Board under the reference number 981-2020. The trial was registered as PACTR, PACTR202102852000433 on January 7, 2021 in and as NCT04844255 on April 14, 2021 in .
: Not applicable.
: The authors declare that they have no competing interests.